Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Urología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 1
ClinicalTrials.gov
A Phase 1 Study to Compare Bempegaldesleukin Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (mRCC) (PIVOT IO 011)
INTERVENTIONAL
Inicio: 11 de sept de 2020
ID: NCT04540705
Completado
Fase 3
ClinicalTrials.gov
A Randomized Double-Blind Phase 3 Trial Comparing Docetaxel Combined With Dasatinib to Docetaxel Combined With Placebo in Castration-Resistant Prostate Cancer
INTERVENTIONAL
Inicio: 1 de oct de 2008
ID: NCT00744497
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Multi-center, Open Label Study of NIR178 in Combination With PDR001 in Patients With Selected Advanced Solid Tumors and Non-Hodgkin Lymphoma
INTERVENTIONAL
Inicio: 28 de ago de 2017
ID: NCT03207867
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects With Castration Resistant Prostate Cancer That Have Received Prior Treatment With Docetaxel
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00861614
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of Aflibercept Versus Placebo Administered Every 3 Weeks in Patients Treated With Docetaxel/ Prednisone for Metastatic Androgen-independent Prostate Cancer
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00519285
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Comparative Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Subjects With High-Risk, Metastatic Hormone-naive Prostate Cancer (mHNPC)
INTERVENTIONAL
Inicio: 12 de feb de 2013
ID: NCT01715285
Desconocido
ClinicalTrials.gov
Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort
OBSERVATIONAL
Inicio: 1 de jun de 2019
ID: NCT04534647
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Study of Neoadjuvant and Adjuvant Nivolumab Plus Bempegaldesleukin (NKTR-214), Versus Nivolumab Alone Versus Standard of Care in Participants With Muscle-Invasive Bladder Cancer (MIBC) Who Are Cisplatin Ineligible
INTERVENTIONAL
Inicio: 5 de feb de 2020
ID: NCT04209114
Completado
ClinicalTrials.gov
Prevalence of Homologous Recombination Repair (HRR) Gene Mutations in Patients With Metastatic Castration-resistant Prostate Cancer in Latin America: PROSPECT Study.
OBSERVATIONAL
Inicio: 21 de abr de 2021
ID: NCT04962880
Completado
ClinicalTrials.gov
Radium-223 Alpha Emitter Agent in Non-intervention Safety Study in mCRPC popUlation for Long-teRm Evaluation
OBSERVATIONAL
Inicio: 20 de ago de 2014
ID: NCT02141438
Completado
ClinicalTrials.gov
Rolandic Epilepsy Genomewide Association International Study
OBSERVATIONAL
Inicio: 1 de jun de 2018
ID: NCT03547050
Terminado
Fase 3
ClinicalTrials.gov
A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer
INTERVENTIONAL
Inicio: 20 de sept de 2019
ID: NCT04066491
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Single-Arm Study of Pralatrexate in Patients With Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
INTERVENTIONAL
Inicio: 1 de jul de 2008
ID: NCT00722553
Completado
Fase 3
ClinicalTrials.gov
A Multinational, Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00679588
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)
INTERVENTIONAL
Inicio: 1 de ene de 2005
ID: NCT00106691
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Cefepime-AAI101 Compared to Piperacillin/Tazobactam in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis.
INTERVENTIONAL
Inicio: 24 de sept de 2018
ID: NCT03687255
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Three-Arm, Randomized, Open-Label Study Of Interferon Alfa Alone, CCI-779 Alone, And The Combination Of Interferon Alfa And CCI-779 In First-Line Poor-Prognosis Subjects With Advanced Renal Cell Carcinoma.
INTERVENTIONAL
Inicio: 1 de jul de 2003
ID: NCT00065468
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab vs Placebo in Participants With Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse
INTERVENTIONAL
Inicio: 7 de jul de 2017
ID: NCT03138512
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Open-label Study of Nivolumab or Nivolumab/BMS-986205 Alone or Combined With Intravesical BCG in Participants With BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer
INTERVENTIONAL
Inicio: 2 de ago de 2018
ID: NCT03519256
Completado
Fase 4
ClinicalTrials.gov
A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
INTERVENTIONAL
Inicio: 1 de may de 2011
ID: NCT01302067
Anterior
1
...
15
16
17
...
434
Siguiente
Filtros